<Record>
<Term>Parasympatholytics</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Autonomic Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Physiological Effects of Drugs/Peripheral Nervous System Agents/Autonomic Agents/Parasympatholytics</ClassificationPath>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Peripheral Nervous System Agents</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Parasympatholytics</BroaderTerm>
<BroaderTerm>Autonomic Agents</BroaderTerm>
<BroaderTerm>Physiological Effects of Drugs</BroaderTerm>
<Synonym>Parasympatholytics</Synonym>
<Synonym>Parasympatholytic Agents</Synonym>
<Synonym>Parasympatholytic Drugs</Synonym>
<Synonym>Parasympathetic-Blocking Agents</Synonym>
<Synonym>Parasympathetic Blocking Agents</Synonym>
<Synonym>Antispasmodics</Synonym>
<Synonym>Antispasmodic Drugs</Synonym>
<Synonym>Spasmolytics</Synonym>
<Synonym>Antispasmodic Agents</Synonym>
<Description>Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.</Description>
<Source>MeSH</Source>
</Record>
